A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs

被引:18
|
作者
Spelman, T. [1 ]
Morris, M. D. [2 ]
Zang, G. [3 ]
Rice, T. [2 ]
Page, K. [4 ]
Maher, L. [5 ]
Lloyd, A. [6 ]
Grebely, J. [5 ]
Dore, G. J. [5 ]
Kim, A. Y. [7 ,8 ]
Shoukry, N. H. [3 ]
Hellard, M. [1 ]
Bruneau, J. [3 ]
机构
[1] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Montreal, CRCHUM, Montreal, PQ H2X 0A9, Canada
[4] Univ New Mexico, Hlth Sci Ctr, Dept Epidemiol Biostat & Prevent Med, Albuquerque, NM 87131 USA
[5] UNSW Australia, Kirby Inst, Sydney, NSW, Australia
[6] UNSW Australia, Sydney, NSW, Australia
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Harvard Univ, Sch Med, Boston, MA USA
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
OPIATE SUBSTITUTION THERAPY; ALCOHOL-CONSUMPTION; RISK BEHAVIOR; LIVER-DISEASE; GLOBAL BURDEN; USERS; EQUIPMENT; IMPACT; HIV; SEROCONVERSION;
D O I
10.1136/jech-2014-205224
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Hepatitis C virus (HCV) testing and counselling have the potential to impact individual behaviour and transmission dynamics at the population level. Evidence of the impact of an HCV-positive status notification on injection risk reduction is limited. The objective of our study was to (1) assess drug and alcohol use and injection risk behaviours following notification; (2) to compare behaviour change in people who inject drugs (PWID) who received a positive test result and those who remained negative; and (3) to assess the effect of age on risk behaviour. Methods Data from the International Collaboration of Incident HIV and HCV Infection in Injecting Cohorts (InC3 Study) were analysed. Participants who were initially HCV seronegative were followed prospectively with periodic HCV blood testing and post-test disclosure and interview-administered questionnaires assessing drug use and injection behaviours. Multivariable generalised estimating equations were used to assess behavioural changes over time. Results Notification of an HCV-positive test was independently associated with a small increase in alcohol use relative to notification of a negative test. No significant differences in postnotification injection drug use, receptive sharing of ancillary injecting equipment and syringe borrowing postnotification were observed between diagnosis groups. Younger PWID receiving a positive HCV test notification demonstrated a significant increase in subsequent alcohol use compared with younger HCV negative. Conclusions The proportion of PWID reporting alcohol use increased among those receiving an HCV-positive notification, increased the frequency of alcohol use postnotification, while no reduction in injection drug use behaviours was observed between notification groups. These findings underscore the need to develop novel communication strategies during post-test notification to improve their impact on subsequent alcohol use and risk behaviours.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
  • [21] Models of care for the management and treatment of hepatitis C virus infection among people who inject drugs
    Conti, F.
    Borghi, A.
    Lanzi, A.
    Bevilacqua, V.
    Vignoli, T.
    Olivoni, D.
    Greco, G.
    Sanza, M.
    Polidori, E.
    Bassi, P.
    Foschi, F. G.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E60 - E61
  • [22] TREATMENT FOR HEPATITIS C VIRUS INFECTION AMONG PEOPLE WHO INJECT DRUGS IN THE OPIOID SUBSTITUTION SETTING: THE ETHOS STUDY
    Alavi, M.
    Grebely, J.
    Micallef, M.
    Dunlop, A.
    Balcomb, A.
    Day, C.
    Treloar, C.
    Bath, N.
    Haber, P.
    Dore, G.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S673 - S673
  • [23] Modeling the spread of hepatitis C virus amongst people who inject drugs
    Greenhalgh, David
    Al-Rashidi, Nader
    ENGINEERING REPORTS, 2022, 4 (10)
  • [24] Hepatitis C virus treatment in people who inject drugs (PWID) in Bangladesh
    Rahman, Mustafizur
    Janjua, Naveed Zafar
    Shafiq, Tanveer Khan Ibne
    Chowdhury, Ezazul Islam
    Sarker, Md. Safiullah
    Khan, Sharful Islam
    Reza, Masud
    Faruque, Mohammad Omar
    Kabir, Ahmedul
    Anis, Aslam H.
    Azim, Tasnim
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2019, 74 : 69 - 75
  • [25] Hepatitis C virus risk among young people who inject drugs
    Mateu-Gelabert, Pedro
    Sabounchi, Nasim S.
    Guarino, Honoria
    Ciervo, Courtney
    Joseph, Kellie
    Eckhardt, Benjamin J.
    Fong, Chunki
    Kapadia, Shashi N.
    Huang, Terry T. K.
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [26] Eradication of Hepatitis C Infection: The Importance of Targeting People Who Inject Drugs
    Hellard, Margaret
    Doyle, Joseph S.
    Sacks-Davis, Rachel
    Thompson, Alexander J.
    McBryde, Emma
    HEPATOLOGY, 2014, 59 (02) : 366 - 369
  • [27] Agent, Host, and Environment: Hepatitis C Virus in People Who Inject Drugs
    Hagan, Holly
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (12): : 1819 - 1821
  • [28] Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs
    Martinello, Marianne
    Dore, Gregory J.
    Matthews, Gail, V
    Grebely, Jason
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2018, 32 (02) : 371 - 393
  • [29] Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study
    Aspinall, E. J.
    Weir, A.
    Sacks-Davis, R.
    Spelman, T.
    Grebely, J.
    Higgs, P.
    Hutchinson, S. J.
    Hellard, M. E.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (01) : 179 - 182
  • [30] Hepatitis C Treatment in People Who Inject Drugs
    Benjamin Eckhardt
    Current Treatment Options in Infectious Diseases, 2016, 8 (4) : 416 - 425